Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in Multiple System Atrophy
NCT01146548Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- May 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluoxetine in multiple system atrophy (MSA), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Unified Multiple System Atrophy Rating Scale at 3 months. Started May 2008; status: completed.
02
Drugs
fluoxetine
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT01146548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01146548.